Last edition
News about "pre-clinical oncology"
Boehringer Ingelheim, SBP Group Sign USD 7.36 Billion Oncology Deal
Boehringer Ingelheim and China's SBP Group have entered into a multi-programme oncology agreement covering six pre-clinical programmes based on ADC and T-cell engager technologies, with potential milestone payments of up to USD 7 billion.
Pre-clinical Oncology | 05/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members